Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-10T06:58:00.212Z Has data issue: false hasContentIssue false
  • English
  • Français

Iodine requirements during pregnancy, lactation and the neonatal period and indicators of optimal iodine nutrition

Published online by Cambridge University Press:  01 December 2007

François Delange
François Delange*
Affiliation:
International Council for Control of Iodine Deficiency Disorders and Department of Pediatrics, University of Brussels, Brussels, Belgium
*
*deceased
Rights & Permissions [Opens in a new window]

Abstract

Objective: This paper re-evaluates the requirements for iodine during pregnancy, lactation and the neonatal period, and formulates original proposals for the median concentrations of urinary iodine (UI) that indicate optimal iodine nutrition during these three critical periods of life. This paper also discusses the measurements that are used to explore thyroid functions during the same periods.

Design: An extensive and critical review of the literature on thyroid physiopathology during the perinatal period.

Setting: Human studies conducted in various regions throughout the world.

Subjects: Pregnant women, lactating women, and newborns.

Results: The following proposals are made after extensive review of the literature: the requirement for iodine by the mother during pregnancy is 250-300 μg day-1; during lactation the requirement is 225-350 μg day-1; and during the neonatal period the requirement of the infant is 90 μg day-1. The median UI that indicates an optimal iodine nutrition during these three periods should be in the range of 150-230 μg day-1. These figures are higher than recommended to date by the international agencies.

Conclusions: Pregnant women and young infants, but especially the second group, are more sensitive to the effects of an iodine deficiency (ID) than the general population because their serum thyroid-stimulating hormone (TSH) and thyroxine are increased and decreased, respectively, for degrees of ID that do not seem to affect thyroid function in the general population. Systematic neonatal thyroid screening using primary TSH could be the most sensitive indicator to monitor the process of ID control.

Keywords

Iodine requirementsPregnancy LactationNeonatesUrinary iodineThyroid-stimulating hormone
Type
Research Paper
Information
Public Health Nutrition , Volume 10 , Issue 12A , December 2007 , pp. 1571 - 1580
Copyright
Copyright © The Authors 2007

Introduction

Iodine deficiency (ID) used to be a major public health problem. As recently as 1990, 28.9% of the world's population was at risk of a deficiency, 12.0% of the population exhibited goitre, 11.2 million individuals were affected by cretinism and another 43 million people had some degree of mental impairment due to ID1. Therefore, ID is the leading cause of preventable mental retardation during childhood. Concerted international action taken since 1990 has aimed at the sustainable elimination of ID disorders using salt iodisation as the main strategy1, Reference Hetzel, Delange, Dunn, Ling, Mannar and Pandav2. Spectacular results have been achieved as the consumption of iodised salt has increased from some 5–10% of households in 1990 to 68% in 19993. In countries where systematic and periodic monitoring has been used, these changes have resulted in a clear-cut improvement in iodine nutrition and thyroid function in the general populationReference Delange, de Benoist, Pretell and Dunn4–Reference Zamrazil, Bilek, Cerovska and Delange6. However, in their latest evaluation of the control of ID in the world, the World Health Organization (WHO) reported that in 126 out of the 192 members states that have data on urinary iodine (UI), only 67 had an optimal status of iodine nutrition (a median UI concentration of between 100 and 200 μg l− 1); 54 countries were still iodine deficient (median UI concentration < 100 μg l− 1); and 4 countries had an excessive iodine intake (median UI concentration >200 μg l− 1)7. Therefore, it appears that major additional efforts are still required in order to reach the goal of the sustained elimination of ID in the world.

However, even in countries that have achieved iodine sufficiency, the status of iodine nutrition in pregnant and lactating women may still be inadequate. For example, in the United States of America, where the status of iodine nutrition is adequate in the general population, with a median UI concentration of 145 μg l− 1, 6.7% of pregnant women are nevertheless affected by moderate to severe ID and have a UI concentration below 50 μg per lReference Hollowell, Staehling, Hannon, Flanders, Gunter, Maberly, Braverman, Pino, Miller and Garbe8. This is probably largely due to the fact that women are recommended to limit their intake of salt during pregnancy, which includes iodised salt, but also because of the metabolic changes that occur during pregnancy and lactation that result in an increased requirement for iodineReference Beckers and Reinwein9–Reference Berghout, Wiersinga, Stanbury, Delange, Dunn and Pandav12. Yet pregnant women are the most sensitive group in the population to the effects of ID, Maternal hypothyroxinaemia due to ID occurring early during gestation, even before the onset of foetal thyroid function, is the cause of irreversible brain damage in the foetus resulting in mental deficiency in the offspringReference DeLong, Robbins and Condliffe13–Reference Zoeller18. Therefore, the question arises of how to ensure and assess adequate iodine nutrition during pregnancy.

The objectives of this paper are:

  1. To review critically, the scientific literature on iodine requirements during pregnancy, lactation and the neonatal period.

  2. To offer practical recommendations regarding the value of the indicators of optimal iodine nutrition during these critical periods of life, with particular emphasis on normative values of UI concentration.

Requirements for iodine during pregnancy, lactation and the neonatal period

Pregnancy

The requirement of a mother for iodine is increased during pregnancy as a result of at least three factors: (1) an increased requirement for thyroxine (T4) in order to maintain normal metabolism in the mother; (2) a transfer of T4 and iodide from the mother to the foetus; and (3) a supposed greater than normal loss of iodide through the kidneys due to an increase in the renal clearance of iodideReference Glinoer11.

Because of these three factors, the recommended dietary intake of iodine during pregnancy is higher than the value of 150 μg day− 1 recommended for non-pregnant adults and adolescents19, 20. When the intake is below the critical threshold of 150 μg day− 1, the iodine balance during pregnancy becomes negativeReference Dworkin, Jacquez and Beierwaltes21. The WHO, the UNICEF and the ICCIDD19 recommend a daily iodine intake of 200 μg day− 1 by pregnant women, a 33% increase. The Institute of Medicine (IOM) of the US Academy of Sciences recommends a higher intake of 220 μg per day20, while other organisations recommend between 175 and 230 μg per dayReference Thomson22, Reference Ladipo23.

During pregnancy, the daily production of T4 in order to maintain the euthyroidism in hypothyroid women increases by 10–150%, with a median increase of 40–50%Reference Reinwein, Jaspers, Kirbas, Zorlu, Beckers and Reinwein24–Reference Glinoer26. This represents an additional 75–150 μg of T4 day− 1, which requires and estimated 50–100 μg of iodine to make.

The amount of T4 transferred from mother to foetus, including the period before the foetal thyroid gland starts to function, has not been quantified, but it has been estimated that up to 40% of the T4 measured in cord blood at birth is of maternal origin (reviewed in reference Reference Morreale de Escobar, Obregon and Escobar del Rey15).

The transfer of iodide from mother to foetus is also difficult to quantify, but three things need to be taken into consideration: that the iodine content of the foetal thyroid gland increases from < 2 μg at 17 weeks of gestationReference Mahillon, Peers, Bourdoux and Delange27 to 300 μg at full termReference Etling28–Reference Savin, Cuejic, Nedic and Radosavljevic31; that the amount of iodine in foetal T4 at term probably averages 500 μgReference Beckers, Beckers and Reinwein32; and that the substitutive dose of T4 in hypothyroid neonates is 50–75 μg per dayReference Fisher33, Reference Van Vliet34. From this, it can be estimated that the transfer of iodide from mother to foetus represents some 50 μg day− 1. The estimate made by the IOM is 75 μg per day20.

It is often stated that the increase in the iodine requirement of mothers during pregnancy is largely due to a greater loss of iodide through the kidney caused by an increase in renal clearanceReference Glinoer11Reference Aboul-Khair, Crooks, Turnbull and Hytten35–Reference Lazarus and Kokandi38. This should serve to decrease the concentration of plasma inorganic iodide (PII) in serum. However, on the contrary, Liberman et al. Reference Liberman, Pino, Fang, Braverman and Emerson39 showed that there is no significant decline in the concentration of PII during pregnancy. In addition, as shown by the data summarised in Table 1 and reported by Dworkin et al. Reference Dworkin, Jacquez and Beierwaltes21, almost all studies of UI concentrations during pregnancy have shown that, in a given environment, the excretion of iodide is almost the same in pregnant women, non-pregnant women and the general population, irrespective of the status of iodine nutrition in each population. Only the studies conducted in Ireland, the United Kingdom and Sri LankaReference Smyth, Hetherton, Smith, Radcliff and O'Herlihy40, Reference Smyth41, in Hong KongReference Kung, Lao, Chau, Tam and Low42, and perhaps in SwitzerlandReference Hess, Zimmermann, Torresani, Bürgi and Hurrell43 have shown a clear-cut increase in UI excretion during pregnancy. The results reported in another Swiss studyReference Brander, Als, Buess, Haldimann, Harder, Hänggi, Herrmann, lauber, Niederer, Zurcher, Burgi and Gerber44 are difficult to interpret because of the surprisingly low concentration of UI in a population known to be iodine sufficientReference Bürgi, Delange, Robertson, McLoughney and Gerasimov45. On the other hand, some studies have shown that the UI concentration decreases during gestationReference Glinoer, de Nayer, Bourdoux, Lemone, Robyn, Van Steirteghem, Kinthaert and Lejeune46–Reference Caron, Hoff, Bazzi, Dufor, Faure, Ghandour, Lauzu, Lucas, Maraval, Mignot, Ressigeac, Vertongen and Grange48. Therefore, it appears that the concept of an increased urinary loss of iodine during pregnancy is not firmly established and certainly cannot be quantified.

Table 1 (a) Comparison of the median or mean (in boldface) urinary iodine (UI) concentration of pregnant women with the general population or with non-pregnant controls using data from countries with no iodine deficiency, (b) Comparison of the median UI concentration of pregnant women with the general population or with non-pregnant controls using data from iodine deficient (ID) countries, 1990–2003. The countries are listed in roughly descending order of the UI concentration of the general population.

a S, sequential, C, cross-sectional.

b T1, T2, T3, T1-2 or T1-3, trimesters of pregnancy; PP, post partum.

c μg day− 1.

d μg g− 1 creatinine.

Finally, it has to be emphasised that there are no data available on the possible storage or loss of iodide from the placenta itself.

Taking all these factors into consideration, it can be estimated that the additional requirement for iodine during pregnancy is at least 100–150 μg day− 1, or 250–300 μg day− 1 in total. The upper estimate is 100% greater than the 150 μg day− 1 recommended for non-pregnant women, and 33% greater than the 200 μg day− 1 suggested by the WHO, the UNICEF and the ICCIDD19. Consequently, the minimum requirement for iodine during pregnancy is at least 250 μg day− 1, and is probably in the range of 250–300 μg day− 1. This figure is higher than 220 μg day− 1 proposed by the IOM20, which did not take into account the increased production of T4 during pregnancy.

Lactation

Considering that the iodine content of breast milk in conditions of iodine sufficiency is in the range of 150–180 μg per lReference Semba and Delange49, Reference Dorea50 (Table 2), and that some 0.5–1.1 l of milk is produced per day for the first 6 months of lactation, the daily excretion of iodine in human milk is estimated to be 75–200 μg day− 1. Consequently, the iodine required by a lactating woman is estimated to be 225–350 μg day− 1. The slight difference, if any, compared with the figure of 290 μg day− 1 recommended by the IOM20, results from the use of recent data on the iodine content of breast milkReference Semba and Delange49, Reference Dorea50.

Table 2 Selected examples of the iodine content of breast milk compiled from Semba & DelangeReference Semba and Delange49 and DoreaReference Dorea50.

Neonatal period

The iodine requirements of neonates and infants were first estimated to be equal to the mean iodine intake of exclusively breastfed neonates and young infants in iodine replete areas. Up to the late 1960s, the iodine content of breast milk of women in such areas was usually around 50 μg l− 1 (reviewed in references Reference Semba and Delange49–Reference Delange and Chandra51). Considering a daily intake of breast milk of 0.6–1.1 l by neonates and young infants, the assumption was made that an infant gets 30–50 μg iodine per day in milk from an adequately fed motherReference Delange, Delange, Dunn and Glinoer52. However, the iodine content of breast milk is critically influenced by the dietary intake of the pregnant and lactating mother, and of the general population, and recently much higher figures have been recordedReference Semba and Delange49, Reference Dorea50. For this reason, the iodine requirement of neonates has been evaluated from metabolic studies by determining the value that results in a situation of positive iodine balance, a state that is required in order to ensure a progressively increasing iodine pool in the thyroid gland of the growing infant. Such iodine balance studies were conducted in healthy preterm and fullterm infants aged approximately 1 month in Belgium, a country with a mildly iodine-deficient populationReference Delange53. These studies, reported extensively elsewhereReference Delange, Delange, Dunn and Glinoer52, indicate that the iodine intake required to achieve a positive iodine balance is at least 15 μg kg− 1 day− 1 in fullterm infants and 30 μg kg− 1 day− 1 in preterm infants. This corresponds approximately to 90 μg day− 1 and is consequently twice as high as the 1989 US recommendations of 40–50 μg per day54, but is still a bit lower than the present recommendation by the IOM of 110 μg per day20.

Indicators of iodine nutrition during pregnancy, lactation and the neonatal period

UI

Since more than 90% of the iodine absorbed by the body eventually appears in the urine, UI excretion is a good marker of recent dietary iodine intakeReference Zoeller18. This means that a median UI concentration ranging from 100 to 199 μg l− 1 in the general population is considered to indicate an adequate iodine intake and optimal iodine nutrition19. Since the requirement for iodine is increased during pregnancy, the median UI concentration during pregnancy that indicates optimal iodine nutrition needs to be higher than 100 μg l− 1. Table 1 shows data from published studies in several countries that compares the UI concentration of pregnant women with the same in the general population. In Table 1, the countries are arbitrarily listed according to a roughly decreasing iodine intake of the general population, starting with ChileReference Liberman, Pino, Fang, Braverman and Emerson39, whose population is exposed to an excessive iodine intake based on criteria given by the WHO, the UNICEF and the ICCIDD19, down to countries in which different degrees of mild to moderate ID have been documented. As indicated earlier, there is a striking similarity between the UI concentration of pregnant women and of the rest of the population in the same country, except in reports from Ireland and the UKReference Smyth, Hetherton, Smith, Radcliff and O'Herlihy40, Reference Smyth41 where values during pregnancy are markedly and systematically higher than in non-pregnant controls. For this reason, it appears difficult to derive a reference value for a UI concentration during pregnancy and lactation from the data collected in countries with no ID, because this value varies from 800 μg l− 1 in ChileReference Liberman, Pino, Fang, Braverman and Emerson39 to 138 μg l− 1 in SwitzerlandReference Hess, Zimmermann, Torresani, Bürgi and Hurrell43, where the median UI in the general population is barely above the lower limit of normal. In Iran, where ID has been successfully eliminatedReference Azizi, Shaikholesmani, Hedayati, Mirmiran, Malekafzali and Kimiagar55, the median UI concentration of pregnant women in four cities was found to vary from 186 to 403 μg l− 1 (see paper by Azizi, this issue) and was roughly the same as values found in the general population in the same citiesReference Azizi, Aminorroya, Hedayati, Rezvanian, Amini and Mirmiran56. The values recorded in Iran during pregnancy are of the same order of magnitude as the 250–300 μg day− 1 recommended as a daily intake based on metabolic studies. And yet, in spite of these relatively high concentrations, Azizi et al. Reference Azizi, Aminorroya, Hedayati, Rezvanian, Amini and Mirmiran56 point out that, even with such medians, some 8% of the values are still below the critical threshold of 100 μg l− 1 for non-pregnant adults. Azizi et al. suggest that the recommended dietary intake of iodine during pregnancy should be still higherReference Azizi, Aminorroya, Hedayati, Rezvanian, Amini and Mirmiran56. However, it has to be recognised that this figure of 8% corresponds almost exactly to the percentage of values (7.2%) below the threshold of 50 μg l− 1, indicating at least a moderate ID in a general population when the median is between 100 and 200 μg per lReference Delange, de Benoist and Bürgi57. This percentage is considered to be acceptableReference Delange, de Benoist and Bürgi57 considering the well-documented day-to-day variation in UI concentration, including during pregnancyReference Rasmussen, Ovesen and Christiansen58–Reference Thomson, Packer, Butler, Duffield, O'Donaghue and Whanger61.

Taking these facts and factors into consideration, it can be concluded that the recommended median value for UI concentration during pregnancy and lactation has to be based on theoretical grounds. If, as in non-pregnant adults, the recommended median UI concentration of 100–200 μg l− 1 corresponds to the recommended intake of 150 μg day− 1, the median UI concentration during pregnancy and lactation should be in the range of 225–350 μg l− 1. If, on the other hand, this recommended median was based on a recommended intake of 225–350 μg day− 1 and a mean daily urinary volume of 1.5 l day− 1, the UI concentration should be in the range of 150–230 μg l− 1, only slightly higher than the value recommended for non-pregnant adults.

It should be noted that the thyroid function and the thyroid volume remained normal during pregnancy in IranReference Azizi, Aminorroya, Hedayati, Rezvanian, Amini and Mirmiran56 as well as in ChileReference Liberman, Pino, Fang, Braverman and Emerson39 for the values of UI concentration twice as high as in Iran, which strongly suggests that these values are not excessive and not a potential source of side effectsReference Delange and Lecomte62, Reference Braverman63. On the contrary, in all countries whose populations experience some degree of ID, where the issue has been investigated, thyroid function is critically impaired during pregnancy and in the neonate, even when it remains normal in the general populationReference Glinoer, Delange, Laboureur, de Nayer, Lejeune, Kinthaert and Bourdoux64–Reference Rotondi, Amato, Biondi, Mazziotti, Buono, Nicchio, Balzano, Bellastella, Glinoer and Carella68. The anomalies are described in the next sub-section.

In summary, it appears that the recommended dietary intake of iodine during pregnancy of 250–300 μg day− 1 and during lactation of 225–350 μg day− 1, should be higher than proposed, especially by the WHO, the UNICEF and the ICCIDD19, and that a median UI concentration in the range of 150–230 μg l− 1 would indicate optimal iodine nutrition during pregnancy and lactation.

Table 3 summarises data from papers published on the median UI concentration of neonates in countries or areas where the population is iodine sufficient and from countries with different degrees of ID. There is a large variation in values, even in iodine-sufficient countries, where concentrations range from 736 μg l− 1 in Hokkaido, JapanReference Harada, Ichihara, Arai, Honma, Matsuura and Fujieda69 where people have an extremely high iodine intakeReference Suzuki, Higuchi, Sawa, Ohtaki and Horiuchi70, to 96 μg l− 1 in StockholmReference Heidemann, Stubbe, Reuss, Schürnbrand, Larsson and Petrykowski71.

Table 3 Median or mean (in boldface) urinary iodine concentration in neonates in countries in three groups: A. Iodine sufficient; B. Mild to moderate iodine deficiency; and C. Severe iodine deficiency.

a FT, fullterm; PT, preterm.N/A, data not available.

Again these data do not help substantially to identify the optimal UI concentration, therefore, it also has to be defined on the basis of theoretical considerations. Based on the iodine requirement of 90 μg day− 1 and a urine volume passed by neonates of about 0.4–0.5 l per dayReference Behrman, Vaughan and Nelson72, the median UI concentration that indicates optimal iodine nutrition in neonates can be estimated to be about 180–225 μg l− 1, but ignoring the fact that the iodine balance of the neonate should also be positive in order to develop an iodine store in the thyroid gland. This concentration, which is higher than recommended for schoolchildren and adults, has been observed when healthy young infants are supplemented with a daily physiological dose of 90 μg day− 1 of iodineReference Delange, Wolff, Gnat, Dramaix, Pilchen and Vertongen73. It is also the value reported in some parts of the United States in which the population is supposed to be iodine sufficientReference Bryant and Zimmerman74, Reference Gordon, Rowitch, Mitchell and Kohane75. On the other hand, published studies in which the UI concentration has been determined simultaneously in mothers at delivery and in neonates during the first days of lifeReference Vermiglio, Presti, Finocchiaro, Battiato, Grasso, Ardita, Mancuso and Trimarchi47, Reference Hnikova, Hromadkova, Wiererova and Bilek76, Reference Tajtakova, Capova, Bires, Sebokova, Petrovicova and Langer77 indicate that these concentrations are almost similar in mothers and neonates. Therefore, based on the assumption of an optimal UI in pregnant mothers, it can be estimated by extrapolation that the concentration of iodine in the urine of neonates should be around 150–230 μg l− 1, which is similar to the figure derived from the iodine requirements of the neonates.

The data reported from neonates in conditions of mild, moderate and severe ID are indeed much lower than ideal, such as < 20 μg l− 1 in German neonatesReference Delange, Heidemann, Bourdoux, Larsson, Vigneri, Klett, Beckers and Stubbe78 before the partly successful implementation of a programme of voluntary salt iodisationReference Gartner79. It is particularly interesting to observe that this concentration progressively increased with time in both Germany and Belgium, for example, following the implementation of programs of iodine supplementationReference Gartner79, Reference Meng, Schindler, Delange, Robertson, McLoughney and Gerasimov80 or silent iodine prophylaxis respectivelyReference Delange, Van Onderbergen, Shabana, Vandemeulebroucke, Vertongen, Gnat and Dramaix81.

In summary, the recommended dietary intake of iodine in neonates is 90 μg day− 1 and the median UI concentration to be expected when this requirement is met is 180–225 μg l− 1, a value similar to the one recommended for pregnant women.

Measurements exploring thyroid function

The final objective of campaigns to correct an ID is not only to normalise the iodine intake and UI concentration, but also to correct or prevent abnormalities of thyroid function and the development of goitre1, Reference Delange, de Benoist, Pretell and Dunn4, 19. The measurements used to test thyroid function and assess iodine nutrition are the concentration in serum of thyrotropin (TSH), total T4 and/or free T4, thyroglobulin (Tg) and triiodothyronine (T3). To determine these variables requires blood, which is more invasive to collect than urine, especially for pregnant women and neonates.

The alterations of thyroid function during pregnancy that occur in conditions of ID are described and commented upon in detail elsewhereReference Glinoer82, and within this supplement to Public Health Nutrition. They are characterised by a progressively decreasing concentration of free T4 in serum and increasing concentrations of TSH and Tg during pregnancy, together with the development of thyroid hyperplasia. These abnormalities occur even in conditions of mild ID when they are not present in the general population in the same area, indicating the hypersensitivity of pregnant women to the effects of an IDReference Glinoer11, Reference Caron, Hoff, Bazzi, Dufor, Faure, Ghandour, Lauzu, Lucas, Maraval, Mignot, Ressigeac, Vertongen and Grange48. They are corrected by giving physiological doses of iodine (reviewed in reference Reference Zimmermann and Delange83) and can be prevented even in conditions of severe ID when injections of iodised oil are given before, or even during, gestation. However, the neurological defects of endemic cretinism are prevented only when the oil is administered before pregnancy beginsReference Delange, de Benoist, Pretell and Dunn4. The value of systematically determining the serum TSH concentration of pregnant women may not be justified in a country in which the population is generally iodine sufficient84.

In contrast to the situation in mothers, the alterations of thyroid function that occur in neonates experiencing ID are qualitatively similar but quantitatively much more marked, including particularly high serum TSH and Tg concentrations. The reason for this particular hypersensitivity to ID by the neonate is due to the small iodine stores in the neonatal thyroid, which has a very fast turnover (reviewed in reference Reference Delange85). For this reason, the proposal was made to use neonatal thyroid screening programs which measure primary TSH as the principal monitoring tool in the evaluation of the degree of ID in communities, and of the effectiveness of programs of iodine supplementation1, Reference Delange85. The neonatal TSH concentration assesses the saturation of receptors of brain cells with thyroid hormones and constitutes the single best indicator of the risk of brain damage and mental retardationReference Delange16. In normal conditions, the proportion of neonates with a TSH concentration above 5 mU l− 1 in whole blood (or 10 mU l− 1 serum) is < 3%1. However, this threshold has to be used cautiously since this percentage can be markedly influenced both by the methods used to collect samples and by the method used to do TSH assays. Another approach with the same concept is to use the recall rate of suspected congenital hypothyroidism in programs of systematic screening. Indeed, in this case, the threshold applied is much higher, usually about 15–25 mU l− 1 whole blood, or 30–50 mU l− 1 serum. By using this threshold, it has been reported in Europe that the recall rate started to increase only when the median UI concentration of newborn populations was below 100 μg per lReference Delange85, a value clearly lower than the recommended UI concentration both for adults and neonates1.

Neonatal thyroid screening has been used as a monitoring tool in an increasing number of countries and regions (reviewed in references Reference Delange85–Reference Ordookhani, Mirmiran, Hedayati, Hajipour and Azizi87) with occasional organisational difficultiesReference Bhatara, Sankar, Unutzer and Peabody88.

Conclusion

Pregnant and lactating women and neonates are the main victims of the effects of ID because of the impact of maternal, foetal and neonatal hypothyroxinaemia on brain developmentReference DeLong, Robbins and Condliffe13–Reference Zoeller18. Therefore, any program to correct ID in a population should pay special attention to these particular groups. However, as yet, there are no firm recommendations presently available on the concentration of UI that indicates optimal iodine nutrition in these groups. This paper constitutes an attempt to propose such normative values. It appears that an extensive review of the literature based, in particular, on the evaluation of UI concentrations recorded in these groups in iodine replete populations does not offer clear answers to the question because of the variability of individual results even in iodine sufficient populations. A first conclusion of this paper is that accurate data should be collected in iodine sufficient countries to compare systematically and at the same time, the UI concentration of the general population, non-pregnant adults, schoolchildren, pregnant and lactating women, and neonates.

However, based on published data, and taking into account the metabolic considerations, it is proposed that the recommended dietary intake of iodine should be 250–300 μg day− 1 for pregnant women, 225–350 μg day− 1 for lactating women and 90 μg day− 1 for neonates and young infants. It is proposed that the median UI concentration that indicates optimal iodine nutrition during pregnancy and lactation should be in the range 150–230 μg l− 1. Recommendations for neonates are more difficult still, not only because of the lack of accurate data, but also because the neonate is not in a steady state of iodine metabolism and the UI concentration probably represents a relatively imprecise estimation of the iodine intake. However, based on data from the literature and taking into account the theoretical considerations, it can be concluded that the median UI concentration that indicates optimal iodine nutrition in the neonate should be in the range of 180–225 μg l− 1, which is almost the same as the value recommended for mothers.

It has to be emphasised again that these concentrations are higher than those recommended for the general population19, and may be linked with side effects in adolescents and non-pregnant adults. For this reason, special attention should be paid to giving iodine supplements, while monitoring the UI concentration during pregnancy and possibly during the neonatal period, in addition to programmes of universal salt iodisation in countries in which there is ID.

Monitoring should include a biochemical evaluation of thyroid function by measuring the serum concentration of TSH, Tg, T4, free T4 and T3. Both mothers and infants, but especially infants, are particularly sensitive to ID as their serum TSH is increased and the T4 concentration decreased, in degrees of ID that do not affect thyroid function in the general population. Systematic neonatal thyroid screening using the concentration of primary TSH is a particularly sensitive index of the degree and impact of ID. After a phase, in which the methods of sampling and doing TSH assays are standardised, it could be the most efficient—if not the single best indicator—used in the process of monitoring the control of ID disorders.

References

1WHO, UNICEF, ICCIDD. Indicators for Assessing Iodine Deficiency Disorders and their Control Through Salt Iodization. Geneva: World Health Organization, 1994 WHO/NUT/94.6, 1–55.Google Scholar
2Hetzel, B, Delange, F, Dunn, J, Ling, J, Mannar, V, Pandav, C. Towards the Global Elimination of Brain Damage Due to Iodine Deficiency. New Delhi: Oxford University Press, 2004.Google Scholar
3WHO, UNICEF, ICCIDD. Progress Towards the Elimination of Iodine Deficiency Disorders (IDD). Geneva: World Health Organization, 1999 WHO/NHD/99.4.Google Scholar
4Delange, F, de Benoist, B, Pretell, E, Dunn, J. Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 2001; 11: 437–47.CrossRefGoogle ScholarPubMed
5Yip, R, Chen, ZP, Ling, J. People's Republic of China. In: Hetzel, B, Delange, F, Dunn, J, ling, J, Mannar, V, Pandav, C, eds. Towards the Global Elimination of Brain Damage Due to Iodine Deficiency. New Delhi: Oxford University Press, 2004; 363–95.Google Scholar
6Zamrazil, V, Bilek, R, Cerovska, J, Delange, F. The elimination of iodine deficiency in the Czech Republic: the steps towards success. Thyroid 2004; 14: 49–56.CrossRefGoogle Scholar
7www3.who.int/whosis/micronutrient (Last accessed: 6 July 2005).Google Scholar
8Hollowell, JG, Staehling, NW, Hannon, WH, Flanders, DW, Gunter, EW, Maberly, GF, Braverman, LE, Pino, S, Miller, DT, Garbe, P. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994). Journal of Clinical Endocrinology and Metabolism 1998; 83: 3401–8.Google Scholar
9Beckers, C, Reinwein, D. The Thyroid and Pregnancy. Stuttgart: Schattauer, 1991.Google Scholar
10Stanbury, JB, Delange, F, Dunn, JT, Pandav, CS. Iodine in Pregnancy. New Delhi: Oxford University Press, 1998.Google Scholar
11Glinoer, D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997; 18: 404–33.CrossRefGoogle ScholarPubMed
12Berghout, A, Wiersinga, W. Thyroid size and thyroid function during pregnancy. In: Stanbury, JB, Delange, F, Dunn, JT, Pandav, CS, eds. Iodine in Pregnancy. New Delhi: Oxford University Press, 1998; 35–54.Google Scholar
13DeLong, GR, Robbins, J, Condliffe, PG. Iodine and the Brain. New York: Plenum Press, 1989 1–379.CrossRefGoogle Scholar
14Stanbury, JB. The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication 1994.Google Scholar
15Morreale de Escobar, G, Obregon, MJ, Escobar del Rey, F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? Journal of Clinical Endocrinology and Metabolism 2000; 85: 3975–87.Google ScholarPubMed
16Delange, F. Iodine deficiency as a cause of brain damage. Postgraduate Medical Journal 2001; 77: 217–20.CrossRefGoogle ScholarPubMed
17Lavado-Autric, R, Auso, E, Carcia-Velasco, JV, Arufe del Carmen, M, Escobar del Rey, F, Berbel, P, Morreale de Escobar, G. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitexture of the progeny. Journal of Clinical Investigation 2003; 111: 1073–82.CrossRefGoogle ScholarPubMed
18Zoeller, RT. Transplacental thyroxine and fetal brain development. Journal of Clinical Investigation 2003; 111: 954–7.CrossRefGoogle ScholarPubMed
19WHO, UNICEF, ICCIDD. Assessment of the Iodine Deficiency Disorders and Monitoring Their Elimination. A Guide For Programme Managers, 2 ed.Geneva: World Health Organization, 2001 WHO/NHD/01.1.Google Scholar
20Institute of Medicine, Academy of Sciences, USA. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington DC: National Academy Press, 2001.Google Scholar
21Dworkin, HJ, Jacquez, JA, Beierwaltes, WH. Relationship of iodine ingestion to iodine excretion in pregnancy. Journal of Clinical Endocrinology and Metabolism 1966; 26: 1329–42.CrossRefGoogle ScholarPubMed
22Thomson, CD. Dietary recommendations of iodine around the world. IDD Newsletter 2002; 18(3): 38–42.Google Scholar
23Ladipo, OA. Nutrition in pregnancy: mineral and vitamin supplements. American Journal of Clinical Nutrition 2000; 72: 280S–90S.CrossRefGoogle ScholarPubMed
24Reinwein, D, Jaspers, C, Kirbas, C, Zorlu, A. Thyroxine substitution during pregnancy. In: Beckers, C, Reinwein, D, eds. The Thyroid and Pregnancy. Stuttgart: Schattauer, 1991; 115–24.Google Scholar
25Toft, A. Increased levothyroxine requirements in pregnancy. Why, when and how much? New England Journal of Medicine 2004; 351: 292–4.CrossRefGoogle ScholarPubMed
26Glinoer, D. The sytematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends in Endocrinology and Metabolism 1998; 9: 403–11.CrossRefGoogle Scholar
27Mahillon, I, Peers, W, Bourdoux, P, Delange, F. Effect of vaginal douching with povidone–iodine during early pregnancy on the iodine supply to mother and fetus. Biology of the Neonate 1989; 56: 210–7.CrossRefGoogle ScholarPubMed
28Etling, N. Concentration of thyroglobulin, iodine contents of thyroglobulin and of iodo-aminoacids in human neonates thyroid glands. Acta Paediatrica Scandinavica 1977; 66: 97–102.CrossRefGoogle Scholar
29Costa, A, Filippis, VD, Panizzo, M, Giraudi, G. Development of thyroid function between VI–IX month of fetal life in humans. Journal of Endocronological Investigation 1986; 9: 273–80.CrossRefGoogle ScholarPubMed
30Delange, F, Bourdoux, P, Laurence, M, Peneva, L, Walfish, P, Willgerodt, H. Neonatal thyroid function in iodine deficiency. In: Delange, F, Dunn, JT, Glinoer, D, eds. Iodine Deficiency in Europe. A Continuing Concern. New York: Plenum Press, 1993; 199–210.CrossRefGoogle Scholar
31Savin, S, Cuejic, D, Nedic, O, Radosavljevic, R. Thyroid hormone synthesis and storage in the thyroid gland of human neonates. Journal of Pediatric Endocrinology and Metabolism 2003; 16: 521–8.CrossRefGoogle ScholarPubMed
32Beckers, C. Iodine economy in and around pregnancy. In: Beckers, C, Reinwein, D, eds. The Thyroid and Pregnancy. Stuttgart: Schattauer, 1991; 25–34.Google Scholar
33Fisher, DA. Management of congenital hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1991; 72: 523–9.CrossRefGoogle ScholarPubMed
34Van Vliet, G. Neonatal hypothyroidism: treatment and outcome. Thyroid 1999; 9: 79–84.CrossRefGoogle ScholarPubMed
35Aboul-Khair, SA, Crooks, J, Turnbull, AC, Hytten, FE. The physiological changes in thyroid function during pregnancy. Clinical Science 1964; 27: 195–207.Google ScholarPubMed
36Wayne, EJ, Koutras, DA, Alexander, WD. Clinical Aspects of Iodine Metabolism. Oxford: Blackwell, 1964.Google Scholar
37Dafnis, E, Sabatini, S. The effect of pregnancy on renal function: physiology and pathophysiology. American Journal of Medical Science 1992; 303: 184–205.CrossRefGoogle ScholarPubMed
38Lazarus, JH, Kokandi, A. Thyroid disease in relation to pregnancy: a decade of change. Clinical Endocrinology 2000; 53: 265–78.CrossRefGoogle ScholarPubMed
39Liberman, CS, Pino, SC, Fang, SL, Braverman, LE, Emerson, CH. Circulating iodide concentrations during and after pregnancy. Journal of Clinical Endocrinology and Metabolism 1998; 83: 3545–9.Google Scholar
40Smyth, PPA, Hetherton, AMT, Smith, DF, Radcliff, M, O'Herlihy, C. Maternal iodine status and thyroid volume during pregnancy: correlation with neonatal iodine intake. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2840–3.CrossRefGoogle ScholarPubMed
41Smyth, PPA. Variation in iodine handling during normal pregnancy. Thyroid 1999; 9: 637–42.CrossRefGoogle ScholarPubMed
42Kung, AWC, Lao, TT, Chau, MT, Tam, SCF, Low, LCK. Goitrogenesis during pregnancy and neonatal hypothyroxinaemia in a borderline iodine sufficient area. Clinical Endocrinology 2000; 53: 725–31.CrossRefGoogle Scholar
43Hess, SY, Zimmermann, MB, Torresani, T, Bürgi, H, Hurrell, RF. Monitoring the adequacy of salt iodization in Switzerland: a national study of school children and pregnant women. European Journal of Clinical Nutrition 2001; 55: 162–6.CrossRefGoogle ScholarPubMed
44Brander, L, Als, C, Buess, H, Haldimann, F, Harder, M, Hänggi, W, Herrmann, U, lauber, K, Niederer, U, Zurcher, T, Burgi, U, Gerber, H. Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland. Journal of Endocrinological Investigation 2003; 26: 389–96.CrossRefGoogle Scholar
45Bürgi, H. Iodine deficiency in Switzerland. In: Elimination of Iodine Deficiency Disorders (IDD) in Central and Eastern Europe, the Commonwealth of Independent States, and the Baltic States. Delange, F, Robertson, A, McLoughney, E, Gerasimov, G, eds. Geneva: WHO publ., 1998 WHO/EURO/NUT/98.1; 15–20.Google Scholar
46Glinoer, D, de Nayer, P, Bourdoux, P, Lemone, M, Robyn, C, Van Steirteghem, A, Kinthaert, J, Lejeune, B. Regulation of maternal thyroid during pregnancy. Journal of Clinical Endocrinology and Metabolism 1990; 71: 276–87.CrossRefGoogle ScholarPubMed
47Vermiglio, F, Presti, VPL, Finocchiaro, MD, Battiato, S, Grasso, L, Ardita, FV, Mancuso, A, Trimarchi, F. Enhanced iodine concentration capacity by the mammary gland in iodine deficient lactating women of an endemic goiter region in Sicily. Journal of Endocrinological Investigation 1992; 15: 137–42.CrossRefGoogle ScholarPubMed
48Caron, P, Hoff, M, Bazzi, S, Dufor, A, Faure, G, Ghandour, I, Lauzu, P, Lucas, Y, Maraval, D, Mignot, F, Ressigeac, P, Vertongen, F, Grange, V. Urinary iodine excretion during normal pregnancy in healthy women living in the Southwest of France: correlation with maternal thyroid parameters. Thyroid 1997; 7: 749–54.CrossRefGoogle ScholarPubMed
49Semba, RD, Delange, F. Iodine in human milk: perspectives for human health. Nutrition Reviews 2001; 59: 269–78.CrossRefGoogle Scholar
50Dorea, JG. Iodine nutrition and breast feeding. Journal of Trace Elements in Medicine and Biology 2002; 16: 207–20.CrossRefGoogle ScholarPubMed
51Delange, F. Physiopathology of iodine nutrition. In: Chandra, RK, ed. Trace Elements in Nutrition of Children. New York: Raven Press, 1985; 291–9.Google Scholar
52Delange, F. Requirements of iodine in humans. In: Delange, F, Dunn, JT, Glinoer, D, eds. Iodine Deficiency in Europe. A Continuing Concern. New York: Plenum Press, 1993; 5–16.CrossRefGoogle Scholar
53Delange, F. Iodine deficiency in Europe anno 2002. Thyroid International 2002; 5: 1–19.Google Scholar
54National Research Council, Food and Nutrition Board. Recommended Dietary Allowances. Washington DC: National Academy Press, 1989; 213–217 and Table p. 285.Google Scholar
55Azizi, F, Shaikholesmani, R, Hedayati, M, Mirmiran, P, Malekafzali, H, Kimiagar, M. Sustainable control of iodine deficiency in Iran. Journal of Endocrinological Investigation 2002; 25: 409–13.CrossRefGoogle ScholarPubMed
56Azizi, F, Aminorroya, A, Hedayati, M, Rezvanian, H, Amini, M, Mirmiran, P. Urinary iodine excretion in pregnant women residing in areas with adequate iodine intake. Public Health Nutrition 2003; 6: 95–8.CrossRefGoogle ScholarPubMed
57Delange, F, de Benoist, B, Bürgi, H. Median urinary iodine concentrations indicating adequate iodine intake at population level. Bulletin of the World Health Organization 2002; 80: 410–7.Google ScholarPubMed
58Rasmussen, LB, Ovesen, L, Christiansen, E. Day-to-day and within-day variation in urinary iodine excretion. European Journal of Clinical Nutrition 1999; 53: 401–7.CrossRefGoogle ScholarPubMed
59Als, C, Helbling, A, Peter, K, Haldimann, M, Zimmerli, B, Gerber, H. Urinary iodine concentration follows a circadian rhythm: a study with 3023 spot urine samples in adults and children. Journal of Clinical Endocrinology and Metabolism 2000; 85: 1367–9.Google Scholar
60Bürgi, H, Bangerter, B, Siebenhüner, L. High day-to-day variability of urinary iodine excretion despite almost universal salt iodization in Switzerland. In: Geertman, RM, ed. 8th World Salt Symposium. Amsterdam: Elsevier, 2000; 961–3.Google Scholar
61Thomson, CD, Packer, MA, Butler, JA, Duffield, AJ, O'Donaghue, KL, Whanger, PD. Urinary selenium and iodine during pregnancy and lactation. Journal of Trace Elements in Medicine and Biology 2001; 14: 210–7.CrossRefGoogle ScholarPubMed
62Delange, F, Lecomte, P. Iodine supplementation: benefits outweigh risks. Drug Safety 2000; 22: 89–95.CrossRefGoogle ScholarPubMed
63Braverman, LE. Adequate iodine intake-the good far outweights the bad. European Journal of Endocrinology 1998; 139: 14–15.CrossRefGoogle Scholar
64Glinoer, D, Delange, F, Laboureur, I, de Nayer, P, Lejeune, B, Kinthaert, J, Bourdoux, P. Maternal and neonatal thyroid function at birth in an area of marginally low iodine intake. Journal of Clinical Endocrinology and Metabolism 1992; 75: 800–5.Google Scholar
65Berghout, A, Endert, E, Ross, A, Hogerzell, HV, Smits, NJ, Wiersinga, WH. Thyroid function and thyroid size in normal pregnant women living in an iodine replete area. Clinical Endocrinology 1994; 41: 375–9.CrossRefGoogle Scholar
66Vermiglio, F, Presti, VPL, Argentina, GS, Finocchiaro, MD, Gullo, D, Squatrito, S, Trimarchi, F. Maternal hypothyroxinemia during the first half of gestation in an iodine deficient area with endemic cretinism and related disorders. Clinical Endocrinology 1995; 42: 409–15.CrossRefGoogle Scholar
67Eltom, A, Eltom, M, Elnagar, B, Elbagir, M, Gebre-Medhin, M. Changes in iodine metabolism during late pregnancy and lactation: a longitudinal study among Sudanese women. European Journal of Clinical Nutrition 2000; 54: 429–33.CrossRefGoogle ScholarPubMed
68Rotondi, M, Amato, G, Biondi, B, Mazziotti, G, Buono, AD, Nicchio, MR, Balzano, S, Bellastella, A, Glinoer, D, Carella, C. Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. Journal of Clinical Endocrinology and Metabolism 2000; 85: 4534–7.CrossRefGoogle ScholarPubMed
69Harada, S, Ichihara, N, Arai, J, Honma, H, Matsuura, N, Fujieda, K. Influence of iodine excess due to iodine-containing antiseptics on neonatal screening for congenital hypothyroidism in Hokkaido prefecture, Japan. Screening 1994; 3: 115–23.CrossRefGoogle Scholar
70Suzuki, H, Higuchi, T, Sawa, K, Ohtaki, S, Horiuchi, Y. ‘Endemic coast goitre’ in Hokkaido, Japan. Acta Endocrinologica (Copenhagen) 1965; 50: 161–76.Google ScholarPubMed
71Heidemann, PH, Stubbe, P, Reuss, KV, Schürnbrand, P, Larsson, A, Petrykowski, WV. Jodausscheidung und alimentäre Jodversorgung bei Neugeborenen in Jodmangelgebieten der Bundersrepublik. Deutsche Medizinische Wochenschrift 1984; 109: 773–8.CrossRefGoogle Scholar
72Behrman, RE, Vaughan, VC, Nelson, WE. Nelson Textbook of Pediatrics, 13 ed.Philadelphia: Saunders, 1987.Google Scholar
73Delange, F, Wolff, P, Gnat, D, Dramaix, M, Pilchen, P, Vertongen, F. Iodine deficiency during infancy and early childhood in Belgium: does it pose a risk to brain development? European Journal of Pediatrics 2001; 160: 251–4.CrossRefGoogle Scholar
74Bryant, WP, Zimmerman, D. Iodine-induced hyperthyroidism in a newborn. Pediatrics 1995; 95: 434–6.CrossRefGoogle ScholarPubMed
75Gordon, CM, Rowitch, DH, Mitchell, ML, Kohane, IS. Topical iodine and neonatal hypothyroidism. Archives of Pediatrics and Adolescent Medicine 1995; 149: 1336–9.CrossRefGoogle ScholarPubMed
76Hnikova, O, Hromadkova, M, Wiererova, O, Bilek, R. Follow-up study of iodine status in neonates and their mothers in 2 regions of the Czech Republic after a 3-year intervention. Casopsis Lekaru Ceskych 1999; 138: 272–5.Google ScholarPubMed
77Tajtakova, M, Capova, J, Bires, J, Sebokova, E, Petrovicova, J, Langer, P. Thyroid volume, urinary and milk iodine in mothers after delivery and their newborns in iodine-replete country. Endocrine Regulations 1999; 33: 9–15.Google ScholarPubMed
78Delange, F, Heidemann, P, Bourdoux, P, Larsson, A, Vigneri, R, Klett, M, Beckers, C, Stubbe, P. Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biology of the Neonate 1986; 49: 322–30.CrossRefGoogle ScholarPubMed
79Gartner, R. IDD status in Germany. Journal of Endocrinological Investigation 2003; 26(Suppl. to n°9): 2223.Google Scholar
80Meng, W, Schindler, A. Iodine supply in Germany. In: Delange, F, Robertson, A, McLoughney, E, Gerasimov, G, eds. Elimination of Iodine Deficiency Disorders (IDD) in Central and Eastern Europe, the Commonwealth of the Independent States, and the Baltic States. Geneva: World Health Organization, 1998 WHO/EURO/NUT/98.1; 21–30.Google Scholar
81Delange, F, Van Onderbergen, A, Shabana, W, Vandemeulebroucke, E, Vertongen, F, Gnat, D, Dramaix, M. Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency: the case of Belgium. European Journal of Endocrinology 2000; 143: 189–96.CrossRefGoogle ScholarPubMed
82Glinoer, D. The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Practice and Research. Clinical Endocrinology and Metabolism 2004; 18: 133–52.CrossRefGoogle ScholarPubMed
83Zimmermann, M, Delange, F. Iodine supplementation of pregnant women in Europe: a review and recommendations. European Journal of Clinical Nutrition 2004; 58: 979–84.CrossRefGoogle Scholar
84Anonymous. American Thyroid Association Symposium and statement focus on maternal thyroid health. American Thyroid Assoiciation Signal. August, 2004.Google Scholar
85Delange, F. Screening for congenital hypothyroidism used as an indicator of IDD control. Thyroid 1998; 8: 1185–92.CrossRefGoogle Scholar
86Choudhury, N, Gorman, KS. Subclinical prenatal iodine deficiency negatively affects infant development in Northern China. Journal of Nutrition 2003; 133: 3162–5.CrossRefGoogle ScholarPubMed
87Ordookhani, A, Mirmiran, P, Hedayati, M, Hajipour, R, Azizi, F. An interim report of the pilot study of screening for congenital hypothyroidism in Tehran and Damavand using cord blood samples. European Journal of Pediatrics 2003; 162: 202–3.CrossRefGoogle Scholar
88Bhatara, V, Sankar, R, Unutzer, J, Peabody, J. A review of the case for neonatal thyrotropin screening in developing countries: the examples of India. Thyroid 2002; 12: 591–8.CrossRefGoogle ScholarPubMed
89Elnagar, B, Eltom, A, Wide, L, Gebre-Medhin, M, Karlsson, FA. Iodine status, thyroid function and pregnancy: study of Swedish and Sudanese women. European Journal of Nutrition 1998; 52: 351–5.Google ScholarPubMed
90Soldin, OP, Soldin, SJ, Pezzullu, JC. Urinary iodine percentile ranges in the United States. Clinica Chimica Acta 2003; 328: 185–90.CrossRefGoogle ScholarPubMed
91Barnett, CA, Visser, TJ, Williams, F, Toor, HV, Duran, S, Presas, MJ, et al. . Inadequate iodine intake of 40% of pregnant women from a region of Scotland. Journal of Endocrinological Investigation 2002; P110(Suppl. to n°7): 90.Google Scholar
92Pearce, EN, Bazrafshan, HR, He, X, Pino, S, Braverman, LE. Dietary iodine in pregnant women from the Boston, Massachusetts area. Thyroid 2004; 14: 327–8.CrossRefGoogle ScholarPubMed
93Kung, AWC, Lao, TT, Low, LCK, Pang, RWC, Robinson, JD. Iodine insufficiency and neonatal hyperthyrotropinemia in Hong Kong. Clinical Endocrinology 1997; 46: 315–9.CrossRefGoogle Scholar
94Vermiglio, F, Presti, VPL, Castagna, MG, Violi, MA, Moleti, M, Finocchiaro, MD, Mattina, F, Artemisia, A, Trimarchi, F. Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid 1999; 9: 19–24.CrossRefGoogle Scholar
95Mocan, MZ, Erem, C, Telatar, M, Mocan, H. Urinary iodine levels in pregnant women with and without goiter in the Eastern Black Sea of Turkey. Trace Elements and Electrolytes 1995; 12: 195–7.Google Scholar
96Pedersen, KM, Laurberg, P, Iversen, E, Knudsen, PR, Gregersen, HE, Rasmussen, OS, Larsen, KR, Eriksen, GM, Johanessen, PL. Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism 1993; 77: 1078–83.Google ScholarPubMed
97Nohr, SB, Laurberg, P, Borlum, KG, Pedersen, KM, Johannesen, PL, Damm, P, Fugsland, E, Johansen, A. Iodine deficiency in pregnancy in Denmark: regional variations and frequency of individual iodine supplementation. Acta Obstetricia Gynecologica Scandinavica 1993; 72: 350–3.CrossRefGoogle ScholarPubMed
98Antonangeli, L, Maccherini, D, Cavaliere, R, Giulio, CD, Reinhardt, B, Pinchera, A, Aghini-Lombardi, F. Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. European Journal of Endocrinology 2002; 147: 29–34.CrossRefGoogle ScholarPubMed
99Romano, R, Jannini, EA, Pepe, M, Grimaldi, A, Olivieri, M, Spennati, P, Cappa, F, D'Armineto, M. The effects of iodoprophylaxis on thyroid size during pregnancy. American Journal of Obstetrics and Gynecology 1991; 164: 482–5.CrossRefGoogle ScholarPubMed
100Liesenkötter, KP, Göpel, W, Bogner, U, Stach, B, Grüters, A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology 1996; 134: 443–8.CrossRefGoogle ScholarPubMed
101Mezosi, E, Molnar, I, Jakab, A, Balogh, E, Karanyi, Z, Pakozdy, Z, Nagy, P, Gyory, F, Szabo, J, Bajnok, L, Leovey, L, Kakyk, G, Nagy, EV. Prevalence of iodine deficiency and goitre during pregnancy in East Hungary. European Journal of Endocrinology 2000; 143: 479–83.CrossRefGoogle ScholarPubMed
102Brown, RS, Bloomfield, S, Bednarek, FJ, Mitchell, ML, Braverman, LE. Routine skin cleaning with povidone–iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 1997; 7: 395–400.CrossRefGoogle Scholar
103Delange, F, Dalhem, A, Bourdoux, P, Lagasse, R, Glinoer, D, Fisher, DA, Walfish, PG, Ermans, AM. Increased risk of primary hypothyroidism in preterm infants. Journal of Pediatrics 1984; 105: 462–9.CrossRefGoogle ScholarPubMed
104Bakker, B, Vulsma, T, Randamie, JD, Achterhuis, AM, Wiedijk, B, Oosting, H, Glas, C, de Vijlder, JJ. A negative iodine balance is found in healthy neonates compared with neonates with thyroid agenesis. Journal of Endocrinology 1999; 161: 115–20.CrossRefGoogle ScholarPubMed
105Grebe, SF, Rebeski, F, Gent, J, Müller, KD. Iodine balance in neonates and their mothers. Klinicheskaia Laboratornaia Diagnostika 1993; 39: 143–6.Google Scholar
106Böhles, H, Aschenbrenner, M, Roth, M, Loewenich, Vv, Ball, F, Usadel, KH. Development of thyroid gland volume during the first 3 months of life in breast-fed versus iodine-supplemented and iodine-free formula-fed infants. Clinical Investigation 1993; 71: 13–20.Google ScholarPubMed
107Grüters, A, Liesenkötter, KP, Willgerodt, H. Persistence of differences in iodine status in newborns after the reunification of Berlin. New England Journal of Medicine 1995; 333: 1429.CrossRefGoogle ScholarPubMed
108Roth, C, Meller, J, Bobrzik, S, Thal, H, Becker, W, Kulenkampff, D, Lakomek, M, Zappel, H. Die Jodversorgung von Neugeborenen. Deutsche Medizinische Wochenschrift 2001; 126: 321–5.CrossRefGoogle Scholar
109Klett, M, Ohlig, M, Manz, F, Tröger, J, Heinrich, U. Effect of iodine supply on neonatal thyroid volume and TSH. Acta Paediatrica 1999; 88: 18–20.CrossRefGoogle ScholarPubMed
110Ciardelli, R, Haumont, D, Gnat, D, Vertongen, F, Delange, F. The nutritional iodine supply of Belgian neonates is still insufficient. European Journal of Pediatrics 2002; 161: 519–23.CrossRefGoogle ScholarPubMed
111Rapa, A, Chiorboli, E, Corbetta, C, Sacco, F, Bona, G, Study, AU. Urinary iodine excretion (UIE) screening in newborns exposed to iodine-containing antiseptics. Hormone Research 1996; 46: 74.Google Scholar
112Parravicini, E, Fontana, C, Paterlini, GL, Tagliabue, P, Rovelli, F, Leung, K, Stark, RI. Iodine, thyroid function and very low birth weight infants. Pediatrics 1996; 98: 730–4.CrossRefGoogle ScholarPubMed
113Bona, G, Chiorboli, E, Rapa, A, Weber, G, Vigone, MC, Chiumello, G. Measurement of urinary iodine excretion to reveal iodine excess in neonatal transient hypothyroidism. Journal of Pediatric Endocrinology and Metabolism 1998; 11: 739–43.CrossRefGoogle ScholarPubMed
114Barakat, M, Carson, D, Hetherton, AM, Smyth, P, Leslie, H. Hypothyroidism secondary to topical iodine treatment in infants with spina bifida. Acta Paediatrica 1994; 83: 741–3.CrossRefGoogle ScholarPubMed
115Linder, N, Davidovitch, N, Reichman, B, Kuint, J, Lubin, D, Meyerovitch, J, Sela, BA, Dolfin, Z, Sack, J. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants. Journal of Pediatrics 1997; 131: 434–9.CrossRefGoogle ScholarPubMed
116Peter, F, Muzsnai, A, Bourdoux, P. Changes of urinary iodine excretion of newborns over a period of twenty years. Journal of Endocrinological Investigation 2003; 26(Suppl. to n°2): 39–42.Google Scholar
Figure 0

Table 1 (a) Comparison of the median or mean (in boldface) urinary iodine (UI) concentration of pregnant women with the general population or with non-pregnant controls using data from countries with no iodine deficiency, (b) Comparison of the median UI concentration of pregnant women with the general population or with non-pregnant controls using data from iodine deficient (ID) countries, 1990–2003. The countries are listed in roughly descending order of the UI concentration of the general population.

Figure 1

Table 2 Selected examples of the iodine content of breast milk compiled from Semba & Delange49 and Dorea50.

Figure 2

Table 3 Median or mean (in boldface) urinary iodine concentration in neonates in countries in three groups: A. Iodine sufficient; B. Mild to moderate iodine deficiency; and C. Severe iodine deficiency.